This antibody was raised by injecting mice intraperitoneally and subcutaneously with Hong Kong influenza virus-stimulated PBMC, which express human IL-2 receptor alpha. Immune splenocytes were subsequently fused with SP2/0 cells to produce stable hybridomas.